HansBiomed Corporation Cash Flow Quality Index
HansBiomed Corporation cash flow quality index. HansBiomed Corporation (042520) has a Cash Flow Quality Index of 1.70x as of June 2024. Operating cash flow of ₩159.13 Million exceeds net income of ₩93.69 Million, indicating high earnings quality where cash backs reported profits. See 042520 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of HansBiomed Corporation (2012–2022)
Cash flow quality index of HansBiomed Corporation from 2012 to 2022. Historical Cash Flow Quality Index for HansBiomed Corporation across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore HansBiomed Corporation (042520) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
HansBiomed Corporation Cash Flow Quality Index by Year (2012–2022)
HansBiomed Corporation cash flow quality index by year from 2012 to 2022. Year-by-year earnings quality comparison for HansBiomed Corporation. For the full cash flow conversion analysis, see 042520 operating cash flow.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.69x | ₩-4.27 Billion | ₩6.15 Billion | ▼ -188.7% |
| 2019 | 0.78x | ₩7.71 Billion | ₩9.85 Billion | ▼ -37.4% |
| 2018 | 1.25x | ₩5.20 Billion | ₩4.16 Billion | ▲ +75.0% |
| 2017 | 0.72x | ₩5.60 Billion | ₩7.83 Billion | ▲ +1179.4% |
| 2016 | -0.07x | ₩-316.10 Million | ₩4.77 Billion | ▼ -109.4% |
| 2015 | 0.71x | ₩3.47 Billion | ₩4.91 Billion | ▲ +19.8% |
| 2014 | 0.59x | ₩2.06 Billion | ₩3.50 Billion | ▼ -13.2% |
| 2013 | 0.68x | ₩2.33 Billion | ₩3.43 Billion | ▲ +14.0% |
| 2012 | 0.60x | ₩1.50 Billion | ₩2.52 Billion | — |